Skip to main content

Table 3 Demographics and clinical characteristics of propensity–matched patients

From: Sex differences between serum total bilirubin levels and cognition in patients with schizophrenia

 

Male (n = 98)

Female (n = 78)

Cognition impairment

group

(n = 49)

Cognition

normal group

(n = 49)

P value

Cognition

impairment group

(n = 39)

Cognition normal group

(n = 39)

P value

Age (years)

38.43 ± 11.90

37.10 ± 11.57

0.513

35.79 ± 11.10

33.90 ± 10.97

0.415

BMI (kg/m2)

24.55 ± 3.96

24.76 ± 3.92

0.989

24.44 ± 3.23

24.72 ± 4.34

0.845

Education (years)

12.16 ± 3.23

12.76 ± 3.06

0.568

13.15 ± 3.65

13.21 ± 2.60

0.848

Hypertension

(yes/no)

0/49

0/49

1

3/36

2/37

1

Diabetes mellitus (yes/no)

2/47

3/46

1

0/39

0/39

1

Total disease duration (months)

171.14 ± 110.28

157.12 ± 135.05

0.325

138.76 ± 135.27

122.20 ± 111.92

0.905

Total PANSS score

61.35 ± 20.11

61.00 ± 19.45

0.904

62.21 ± 17.77

55.31 ± 16.32

0.049*

TBIL (μmol/L)

11.05 ± 5.01

14.98 ± 8.75

0.03*

11.87 ± 4.72

9.96 ± 6.04

0.015*

TC (mmol/L)

4.47 ± 0.98

4.59 ± 0.81

0.134

4.57 ± 0.89

4.68 ± 1.36

0.916

TG (mmol/L)

1.80 ± 1.80

1.74 ± 1.11

0.654

1.52 ± 0.88

2.08 ± 5.14

0.325

LDL (mmol/L)

2.80 ± 0.81

2.98 ± 0.84

0.134

2.83 ± 1.65

2.58 ± 0.75

0.853

HDL (mmol/L)

1.09 ± 0.29

1.29 ± 1.33

0.601

1.38 ± 0.46

1.36 ± 0.27

0.503

Mean chlorpromazine equivalent (mg)

542.84 ± 350.92

578.97 ± 314.36

0.611

644.79 ± 320.76

614.42 ± 308.44

0.671

  1. Values are presented as the mean ± SD. *p < 0.05. PANSS Positive and negative syndrome scale. TBIL total bilirubin. TC total cholesterol. TG triglyceride. LDL low density lipoprotein. HDL high density lipoprotein